Apollo report warns of rising hidden heart risks in India

IMT News Desk
IMT News Desk
· 3 min read

Apollo Hospitals has released its Health of the Nation Report 2025, revealing alarming trends in cardiovascular health across India. The findings show that heart disease is striking younger people, often silently, with non-communicable diseases (NCDs) like diabetes, hypertension, obesity, and fatty liver significantly raising cardiac risks.

Silent threats: Asymptomatic but at risk

Of 3,106 individuals screened with no prior history of heart disease, 58% were asymptomatic. Yet, nearly half (46%) had calcium deposits in their arteries, indicating early atherosclerosis. Even more concerning, 25% of them were already living with obstructive coronary artery disease (CAD) requiring urgent treatment. Strikingly, 2.5% of those with deposits were under 40, proving that young Indians are far from immune.

Women’s heart health: Postmenopausal surge in risk

The report highlights a sharp rise in cardiovascular risks among women post menopause. Estrogen’s protective effect diminishes after the age of 55, leading to a surge in heart attacks. After menopause, the prevalence of diabetes, hypertension, and dyslipidemia climbs steeply, making comprehensive postmenopausal heart care a critical need.

Fatty liver: A hidden cardiac risk

Liver health emerged as a powerful predictor of heart disease. Apollo’s data shows 65% of those screened had fatty liver, but more than half displayed normal blood tests—suggesting imaging is essential for diagnosis. With obesity, diabetes, and cholesterol driving most fatty liver cases (MASLD), the report warns of a strong metabolic connection between liver disease and cardiovascular illness.

Hypertension, obesity, and diabetes fuel the fire

India’s rising rates of high blood pressure, excess weight, and diabetes are compounding cardiac risk:

  • Hypertension affects up to 39% of women and 31% of men above 55.
  • Obesity prevalence crosses 70% in older adults, weakening metabolic and heart health.
  • Diabetes, long considered an urban epidemic, is now widespread across age groups, with nearly 1 in 3 adults aged 40–55 affected.

Physical fitness decline and heart risk

Poor muscle strength, flexibility, and balance were observed in 78% of people screened, including younger age groups. Reduced strength and mobility are increasingly linked not only to frailty but also to heart health outcomes, reinforcing the importance of exercise and strength training from early adulthood.

The call for preventive heart care

Emphasizing the urgency, Dr. Prathap C. Reddy, Founder-Chairman of Apollo Hospitals, said: When we founded Apollo Hospitals, our purpose was simple: to save hearts and lives and restore hope. Four decades later, the science is clear – waiting for symptoms is waiting too long. ‘Don’t Miss a Beat’ is a call to every Indian household to know your blood pressure and your numbers, sleep well, be active, and seek timely medical advice. As a pioneer in cardiac care, Apollo brings trusted clinicians and advanced, data-led tools together so that risk is found early and treatment is precise. If India embraces prevention as a daily discipline, we will add millions of healthy years and spare millions of families’ needless loss – one heartbeat at a time.”

Read Next

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules
News
June 11, 2026

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules

Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of […]
Article by: IMT News Desk
DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 
News
June 11, 2026

DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 

DFE Pharma has earned its third consecutive Gold Medal from EcoVadis, the world leader in corporate sustainability assessments, in recognition of its strong performance in the four themes rated: Environment, Labor & Human Rights, Ethics and Sustainable Procurement. This distinction places DFE Pharma in the top 5% of companies, reflecting the company’s focused efforts to […]
Article by: IMT News Desk
Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India
News
June 11, 2026

Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India

Oval Advanced Fertility Care and Merck Specialities Private Limited, the Indian healthcare arm of Merck KGaA, Darmstadt, Germany and a global leader in fertility sciences with decades of scientific leadership in reproductive medicine, have signed a strategic Memorandum of Understanding (MOU).   India’s IVF market, valued at approximately USD 2.35 billion in 2024, is projected […]
Article by: IMT News Desk
Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global
News
June 11, 2026

Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global

Bengaluru-based precision oncology startup 4baseCare has raised ₹128 crore in its ongoing Series B funding round to expand its hospital-linked genomics laboratory network globally and scale its AI-powered precision oncology platform, OncoTwin. The latest funding round, which follows a first close of ₹90 crore co-led by Ashish Kacholia and Lashit Sanghvi with participation from existing […]
Article by: IMT News Desk